» Articles » PMID: 15074710

Challenges for the Development of Ribonucleoside Analogues As Inducers of Error Catastrophe

Overview
Publisher Sage Publications
Date 2004 Apr 13
PMID 15074710
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

RNA viruses are responsible for numerous human diseases; some of these viruses are also potential agents of bioterrorism. In general, the replication of RNA viruses results in the incorporation of at least one mutation per round of replication, leading to a heterogeneous population, termed a quasispecies. The antiviral nucleoside ribavirin has been shown to cause an increase in the mutation frequency of RNA viruses. This increase in mutation frequency leads to a loss of viability due to error catastrophe. In this article, we review lethal mutagenesis as an antiviral strategy, emphasizing the challenges remaining for the development of lethal mutagenesis into a practical clinical approach.

Citing Articles

A Virus Is a Community: Diversity within Negative-Sense RNA Virus Populations.

Gonzalez Aparicio L, Lopez C, Felt S Microbiol Mol Biol Rev. 2022; 86(3):e0008621.

PMID: 35658541 PMC: 9491172. DOI: 10.1128/mmbr.00086-21.


Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1.

Dapp M, Bonnac L, Patterson S, Mansky L J Virol. 2013; 88(1):354-63.

PMID: 24155391 PMC: 3911745. DOI: 10.1128/JVI.02444-13.


Molecular dynamics simulations of viral RNA polymerases link conserved and correlated motions of functional elements to fidelity.

Moustafa I, Shen H, Morton B, Colina C, Cameron C J Mol Biol. 2011; 410(1):159-81.

PMID: 21575642 PMC: 3114172. DOI: 10.1016/j.jmb.2011.04.078.


Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses.

Wu R, Smidansky E, Oh H, Takhampunya R, Padmanabhan R, Cameron C J Med Chem. 2010; 53(22):7958-66.

PMID: 20964406 PMC: 2990348. DOI: 10.1021/jm100593s.


Therapeutically targeting RNA viruses via lethal mutagenesis.

Graci J, Cameron C Future Virol. 2009; 3(6):553-566.

PMID: 19727424 PMC: 2630198. DOI: 10.2217/17460794.3.6.553.